Abstracts
Showing 737 abstracts.
Functionality and Determinants of Antibody Responses to H1N1 pandemic Inactivated Vaccine (pH1N1 vaccine) in HIV-Infected Children, Adolescents and Youth
Conference
IDWeek 2013
Study
P1088
Omitting NRTIs from ARV regimens is not inferior to adding NRTIs in treatment experienced HIV+ subjects failing a PI regimen: The ACTG OPTIONS study
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
A5241
Absent HIV-Specific Immune Responses and Replication-Competent HIV- Reservoirs in Perinatally-Infected Youth treated from Infancy: Towards Cure
Conference
20th Conference on Retroviruses and Opportunistic Infections
Functional HIV Cure after Very Early Antiretroviral Therapy of an Infected Infant.
Conference
20th Conference on Retroviruses and Opportunistic Infections
24 and 48 Week Results from IMPAACT P1066: Raltegravir (RAL) Granules for Suspension (GFS) Formulation in Infants 4 Weeks (wks) to 6 Months (mos) of age
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1066
Efficacy and safety of 6 months versus 6 weeks extended nevirapine (NVP) for prevention of postnatal HIV-1 transmission (PMTCT): 18 month follow-up of the HPTN 046 randomized double blind placebo controlled trial.
Conference
20th Conference on Retroviruses and Opportunistic Infections
Severe immunodeficiency in children starting ART in low-, middle- and high-income countries
Conference
20th Conference on Retroviruses and Opportunistic Infections
Microarray analysis reveals novel insights into immunity to H1N1/09 influenza vaccine in HIV infected children and adolescents in IMPAACT protocol 1088
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1088
Higher Regulatory B and T Cell Rates Are Associated with Decreased Immune Responses to pH1N1 Influenza Vaccine in HIV-Infected Children and Youth
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1088
Pharmacokinetics of Lopinavir/ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines: Interim Results from IMPAACT P1083
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1083